The Orazom drug delivery system is ideally suited for highly lipophilic drugs that are characterized by low bioavailability, high variability between individual patients and an unpredictable dependence on food in the gastrointestinal tract.  Potentially potent drugs are frequently discarded as development candidates because of the absence of biological activity caused by poor absorption.  Application of Orazom to a lipophilic drug allows the drug compound to be packaged in powdered delivery system for dispersion in an aqueous medium to permit efficient absorption.

Zomanex is available to explore innovative partnerships with drug development companies that may be interested in licensing the Orazom delivery system.